Cadence Design Systems, Inc. has announced an expansion of its collaboration with NVIDIA, introducing two groundbreaking solutions that leverage accelerated computing and generative AI. These innovations aim to revolutionize data center design, simulation, drug discovery, and therapeutic design.
Cadence Reality Digital Twin Platform:
The Cadence Reality Digital Twin Platform is a comprehensive solution designed to accelerate the design, simulation, and optimization of data centers across various industries. By leveraging AI, high-performance computing (HPC), and physics-based simulation, the platform significantly improves data center energy efficiency by up to 30%. Integration with NVIDIA Omniverse enhances data center design and simulation workflows, resulting in a 30x acceleration.
Generative AI in Drug Discovery:
Cadence and NVIDIA are collaborating to accelerate drug discovery processes using generative AI. Cadence’s cloud-native molecular design platform, Orion, will integrate NVIDIA’s generative AI tool, BioNeMo, and microservices for drug discovery. This collaboration aims to enhance therapeutic design capabilities and reduce the time to obtain trusted results. Pharmaceutical companies can leverage on-demand GPU access to generate and assess design hypotheses across various therapeutic modalities.
Insights from Executives:
Dr. Anirudh Devgan, President and CEO of Cadence, emphasizes the transformative impact of the collaboration, particularly in data center design and drug discovery. He highlights the integration of AI technologies to optimize data center operations and drive innovation in therapeutics.
Jensen Huang, Founder and CEO of NVIDIA, recognizes the potential of digital twin technology and generative AI to revolutionize industries. He applauds Cadence’s use of NVIDIA Omniverse and generative AI technologies to deliver simulation and digitalization capabilities with far-reaching benefits.
Importance of Digital Twin Technology:
Digital twin technology plays a crucial role in simulating the behavior and performance of complex data center systems. Cadence Reality platform enables designers and operators to visualize data center performance, simulate cooling systems, and plan for various scenarios. The collaboration with NVIDIA expands the capabilities of the Orion drug discovery platform, enhancing molecular design and structure prediction.
Continued Collaboration and Strategic Partnership:
Cadence and NVIDIA have a long-standing collaboration in various domains, including AI-driven IC design, hardware and software verification, and system design and analysis. Today’s announcements underscore their commitment to driving innovation and delivering differentiated products across multiple industries.
Conclusion:
The collaboration between Cadence and NVIDIA represents a significant milestone in advancing generative AI and accelerated computing. By combining their expertise, the companies aim to revolutionize data center design, simulation, drug discovery, and therapeutic design, ultimately driving innovation across diverse market verticals.
About Cadence:
Cadence is a leading provider of electronic systems design solutions, offering software, hardware, and IP to turn design concepts into reality. With a focus on Intelligent System Design, Cadence serves a wide range of industries, including hyperscale computing, communications, automotive, aerospace, healthcare, and more.
